From Ro Khanna <[email protected]>
Subject Life-saving medication doesn’t work if you can’t afford it
Date November 29, 2023 6:37 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
[link removed] [[link removed]]


John,

A recent report found that Pfizer is marketing Paxlovid, one of the few antiviral medications that works to treat COVID-19, for nearly $1400 for a single course [[link removed]] . That’s more than 100 times what it costs to produce and more than double what it charged the U.S. government to distribute the medication free of charge during the pandemic.

Life-saving medication is a necessity, not a luxury. Those at the highest risk for COVID-related hospitalization, namely older and immunocompromised people, will soon be unable to get what they need to avoid a costly hospital stay.

Sign if you agree: We need to cap what Big Pharma charges for medication to ensure everyone who needs it can get it. [[link removed]]

[link removed] [[link removed]]

Americans pay more for their medications than any other country. Over 9 million Americans [[link removed].] tried to save money by skipping doses of their medications in 2021, while Big Pharma’s price gouging and lobbying efforts resulted in a staggering $38.7 billion [[link removed]] in profits the following year.

No matter the condition, we have an obligation to ensure that all Americans can access the medications they need.

Tell Congress: Cap prescription prices. [[link removed]]

Sign the Petition [[link removed]]

Thank you for your activism and all that you do.

In solidarity,
Ro


DONATE [[link removed]]

[link removed] [[link removed]] [link removed] [[link removed]] [link removed] [[link removed]] [email protected] [[email protected]]

Ro for Congress
P.O Box 3513
Santa Clara, CA 95051
United States

Paid for by Ro for Congress

If you believe you received this message in error or wish to no longer receive email from us, please unsubscribe: [link removed] .
Screenshot of the email generated on import

Message Analysis